At its Capital Markets Day, BAT covered four key areas concerning its business: NGP, FDA regulation, GDB’s performance and the US performance. We note the following major points: • NGP: BAT expects to generate NGP revenue of over £0.5bn this year and over £1bn in FY18 (c.£0.6bn in THP and c.£0.4bn in Vapor) reaching $5bn in FY22 (c.£3.5bn in THP and c.£1.5bn in Vapor). The NGP is expected to break-even by the end of 2018 and to deliver substantia
06 Nov 2017
CMD: Course on NGP
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
CMD: Course on NGP
British American Tobacco p.l.c. (BATS:LON) | 2,310 392.8 0.7% | Mkt Cap: 51,549m
- Published:
06 Nov 2017 -
Author:
Anna Zyniewicz -
Pages:
2
At its Capital Markets Day, BAT covered four key areas concerning its business: NGP, FDA regulation, GDB’s performance and the US performance. We note the following major points: • NGP: BAT expects to generate NGP revenue of over £0.5bn this year and over £1bn in FY18 (c.£0.6bn in THP and c.£0.4bn in Vapor) reaching $5bn in FY22 (c.£3.5bn in THP and c.£1.5bn in Vapor). The NGP is expected to break-even by the end of 2018 and to deliver substantia